ATE22800T1 - Verwendung von n-(diethylaminoethyl)-2-methoxy-5methylsulfonylbenzamiden zur hemmung von tryptophanepyrrolasen. - Google Patents

Verwendung von n-(diethylaminoethyl)-2-methoxy-5methylsulfonylbenzamiden zur hemmung von tryptophanepyrrolasen.

Info

Publication number
ATE22800T1
ATE22800T1 AT83401236T AT83401236T ATE22800T1 AT E22800 T1 ATE22800 T1 AT E22800T1 AT 83401236 T AT83401236 T AT 83401236T AT 83401236 T AT83401236 T AT 83401236T AT E22800 T1 ATE22800 T1 AT E22800T1
Authority
AT
Austria
Prior art keywords
diethylaminoethyl
methoxy
tryptophanepyrrolases
inhibit
administering
Prior art date
Application number
AT83401236T
Other languages
English (en)
Inventor
Denis Dr Besancon
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Application granted granted Critical
Publication of ATE22800T1 publication Critical patent/ATE22800T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
AT83401236T 1982-06-17 1983-06-16 Verwendung von n-(diethylaminoethyl)-2-methoxy-5methylsulfonylbenzamiden zur hemmung von tryptophanepyrrolasen. ATE22800T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8210565A FR2528702A1 (fr) 1982-06-17 1982-06-17 Application du n-(diethylaminoethyl) 2-methoxy-5-methylsulfonyl benzamide dans l'inhibition de la tryptophane pyrrolase
EP83401236A EP0099775B1 (de) 1982-06-17 1983-06-16 Verwendung von N-(Diethylaminoethyl)-2-methoxy-5-methylsulfonylbenzamiden zur Hemmung von Tryptophanepyrrolasen

Publications (1)

Publication Number Publication Date
ATE22800T1 true ATE22800T1 (de) 1986-11-15

Family

ID=9275096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83401236T ATE22800T1 (de) 1982-06-17 1983-06-16 Verwendung von n-(diethylaminoethyl)-2-methoxy-5methylsulfonylbenzamiden zur hemmung von tryptophanepyrrolasen.

Country Status (8)

Country Link
US (1) US4485115A (de)
EP (1) EP0099775B1 (de)
JP (1) JPS5916823A (de)
AT (1) ATE22800T1 (de)
DE (2) DE3320187A1 (de)
FR (1) FR2528702A1 (de)
HK (1) HK56189A (de)
IT (1) IT1203657B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6245371A (ja) * 1985-08-24 1987-02-27 Toyota Motor Corp 車両ボデ−外板の塗装方法およびその装置
JPH0767544B2 (ja) * 1986-12-27 1995-07-26 トヨタ自動車株式会社 回転霧化静電塗装装置
EP0520325A1 (de) * 1991-06-28 1992-12-30 F.Hoffmann-La Roche & Co. Aktiengesellschaft Verwendung von Monoaminoxidase-B-Hemmern zur Verhütung und Behandlung von Entzugserscheinungen nach Alkohol- und Drogenmissbrauch
EP1380292A1 (de) * 2002-07-03 2004-01-14 Mewicon med. wiss. Beratung GmbH Tiaprid zur Behandlung von Depressionen
US20040224031A1 (en) * 2003-05-06 2004-11-11 Antonio Zorzano Olarte Combination of amines and vanadium (IV)/(V) compounds for the treatment and/or prevention of diabetes mellitus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791677A (fr) * 1972-07-19 1973-03-16 Renfag Sa Procede de preparation de n-(diethylaminoethyl)-2- methoxy-5-methylsulfonyl-benzamide
FR2243187B1 (de) * 1973-09-10 1978-12-29 Ile De France
FR2305176A1 (fr) * 1975-03-28 1976-10-22 Ile De France Nouveau medicament a base de n-(diethylaminoethyl) 2-methoxy-5-methyl-sulfonyl benzamide
JPS5283621A (en) * 1976-01-01 1977-07-12 Yamanouchi Pharmaceut Co Ltd N-benzyl-n, -benzylethyldiamine derivative

Also Published As

Publication number Publication date
FR2528702B3 (de) 1985-04-19
DE3320187A1 (de) 1983-12-22
US4485115A (en) 1984-11-27
IT1203657B (it) 1989-02-15
DE3366834D1 (en) 1986-11-20
IT8348506A0 (it) 1983-06-15
JPH0344050B2 (de) 1991-07-04
FR2528702A1 (fr) 1983-12-23
JPS5916823A (ja) 1984-01-28
HK56189A (en) 1989-07-21
EP0099775A1 (de) 1984-02-01
EP0099775B1 (de) 1986-10-15

Similar Documents

Publication Publication Date Title
BR7601489A (pt) Processo para a preparacao de uma suspensao aquosa,bombeavel,contendo peroxido organico e suspensao aquosa obtida
PT87039A (pt) Treatment of human viral infections by dsrna combined with viral inhibitors
IT1094660B (it) Procedimento per la concentrazione di soluzioni con contemporaneo indurimento
ES528393A0 (es) Un articulo con un aspecto similar al del cuero
DE3883606D1 (de) Verwendung von Fluoxetin zur Behandlung des Diabetes.
IT1115334B (it) Composizione e procedimento per il trattamento di fibre cheratinose
DK472688A (da) Anvendelse af bezafibrat til behandling af diabetes
ATE22800T1 (de) Verwendung von n-(diethylaminoethyl)-2-methoxy-5methylsulfonylbenzamiden zur hemmung von tryptophanepyrrolasen.
DE3584926D1 (de) Behandlung von oedemen mit hohem proteingehalt durch direktes aufbringen von benzopyronen.
IT967388B (it) Processo e impianto di fraziona mento per adsorbimento
FI844020A0 (fi) Framstaellning av diarylindan-1,3-dioner och anvaendning av dessa.
BE588135A (fr) Stabilisation des solutions d'acrylamides vis-à-vis de la polymérisation.
FR1252201A (fr) Procédé d'amélioration et de vieillissement activé des eaux-de-vie de bouche
BR7401618D0 (pt) Processo para tratar agua com carvao ativo
DE3772764D1 (de) Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl)-methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung.
CH433295A (de) Verwendung von 2-Hydroxy-2',4,5-trimethylbenzophenon zur Stabilisierung
DE3684825D1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
CH407980A (de) Verfahren zur Herstellung von 1,1'-(Alkylen)-bis-(5-arylbiguaniden
ES462239A1 (es) Un metodo para reducir el contenido de alfa-acetileno de unafraccion de hidrocarburo.
IT947650B (it) Perfezionamenti relativi al tratta mento di effluenti
BR7905005A (pt) Processo para aumentar o tempo efetivo de processamento de uma bandagem ortopedica,e bandagem ortopedica assim aperfeicoada
CH389612A (de) Verfahren zur Herstellung von N-(1,3-Dioxy-2-propyl)-2-morpholonen
ATE87207T1 (de) Azapropazon zur praevention von post-ischaemischem gewebeschaden.
AT330792B (de) Verfahren zur herstellung von n-(4- (beta- (2-methoxy -5- chlor-benzamido) -athyl) -benzolsulfonyl) -n'- cyclohexylharnstoff
ATE5229T1 (de) Nasenspange zur prophylaktischen oder therapeutischen behandlung von rindern.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time